Cheng D Y, DeWitt B J, Suzuki F, Neely C F, Kadowitz P J
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Am J Physiol. 1996 Jan;270(1 Pt 2):H200-7. doi: 10.1152/ajpheart.1996.270.1.H200.
Adenosine produces tone-dependent pulmonary vascular responses; however, the adenosine receptor subtype mediating these responses is unknown. In the present study, the adenosine receptor subtypes mediating tone-dependent responses were investigated, Intralobar injections of adenosine,ATP, and analogues under low-tone conditions caused dose-related increases in lobar arterial pressure; the order of potency was alpha,beta-methylene ATP (alpha,beta-metATP) > N6-cyclopentyladenosine (CPA) > ATP > adenosine. Under low-tone conditions, pressor responses to adenosine, ATP, and CPA, an adenosine A1-receptor agonist, were reduced by KW-3902, an adenosine A1-receptor antagonist, whereas KW-3902 and meclofenamate had no effect on responses to alpha,beta-metATP, norepinephrine, serotonin, or angiotensin II. Under elevated-tone conditions, injections of adenosine, ATP, and analogues caused dose-related decreases in lobar arterial pressure, and adenosine was 10-fold less potent than 5'-(N-cyclopropyl)-carboxamidoadenosine (CPCA), an A2-receptor agonist, and ATP. KF-17837, an A2-receptor antagonist, reduced vasodilator responses to adenosine and CPCA, whereas responses to ATP, isoproterenol, diethylamine-NO, lemakalim, and bradykinin were not changed. The vasodilator responses to adenosine were not attenuated by Nw-nitro-L-arginine benzyl ester, methylene blue, or U-37883A. These results suggest that vasoconstrictor responses to adenosine are mediated by A1 receptors and the release of vasoconstrictor prostanoids, and that, under elevated-tone conditions, vasodilator responses are mediated by A2 receptors but not the release of nitric oxide or the activation of guanylate cyclase or K+ATP channels.
腺苷可产生与张力相关的肺血管反应;然而,介导这些反应的腺苷受体亚型尚不清楚。在本研究中,对介导与张力相关反应的腺苷受体亚型进行了研究。在低张力条件下,叶内注射腺苷、ATP及其类似物可引起叶动脉压呈剂量相关的升高;其效力顺序为α,β-亚甲基ATP(α,β-metATP)>N6-环戊基腺苷(CPA)>ATP>腺苷。在低张力条件下,腺苷A1受体拮抗剂KW-3902可降低对腺苷、ATP和腺苷A1受体激动剂CPA的升压反应,而KW-3902和甲氯芬那酸对α,β-metATP、去甲肾上腺素、5-羟色胺或血管紧张素II的反应无影响。在高张力条件下,注射腺苷、ATP及其类似物可引起叶动脉压呈剂量相关的降低,且腺苷的效力比A2受体激动剂5'-(N-环丙基)-羧酰胺腺苷(CPCA)和ATP低10倍。A2受体拮抗剂KF-17837可降低对腺苷和CPCA的血管舒张反应,而对ATP、异丙肾上腺素、二乙胺-NO、雷马卡林和缓激肽的反应未改变。对腺苷的血管舒张反应不受Nω-硝基-L-精氨酸苄酯、亚甲蓝或U-37883A的减弱。这些结果表明,对腺苷的血管收缩反应由A1受体和血管收缩性前列腺素的释放介导,并且在高张力条件下,血管舒张反应由A2受体介导,而非一氧化氮的释放、鸟苷酸环化酶的激活或K+ATP通道的激活。